Surgery Partners, Inc.
$14.31
▼
-0.65%
2026-04-21 09:23:01
www.surgerypartners.com
NMS: SGRY
Explore Surgery Partners, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$1.85 B
Current Price
$14.31
52W High / Low
$24.18 / $11.41
Stock P/E
—
Book Value
$13.37
Dividend Yield
—
ROCE
6.27%
ROE
2.76%
Face Value
—
EPS
$-0.61
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Care Facilities
Employees
16,000
Beta
1.99
Debt / Equity
114.51
Current Ratio
1.87
Quick Ratio
1.71
Forward P/E
33.53
Price / Sales
0.5
Enterprise Value
$7.27 B
EV / EBITDA
11.09
EV / Revenue
2.2
Rating
Buy
Target Price
$18.8
EPS Forecast (FY)
—
Pros
- Short-term liquidity looks comfortable.
- Strong operating margin profile.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Leverage is relatively high.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | NewGenIvf Group Limited | $2.19 | 0.08 | $1.32 M | — | -135.35% | 79.4% | $7,356 / $1.52 | $110.5 |
| 2. | Addus HomeCare Corporation | $93.52 | 18.23 | $1.75 B | — | 10.76% | 9.33% | $124.44 / $90.89 | $59.84 |
| 3. | Enhabit, Inc. | $13.72 | — | $702.56 M | — | 6.13% | -0.46% | $14.22 / $6.47 | $10.53 |
| 4. | biote Corp. | $2.24 | 3.25 | $87.8 M | — | 56.77% | -32.89% | $4.75 / $1.27 | $-1.91 |
| 5. | AMN Healthcare Services, Inc. | $20.46 | — | $790.91 M | — | 2.19% | -14.19% | $23.74 / $14.87 | $16.7 |
| 6. | AirSculpt Technologies, Inc. | $2.64 | — | $180.6 M | 0% | -0.99% | -14.06% | $12 / $1.51 | $1.36 |
| 7. | The Oncology Institute, Inc. | $3.52 | — | $349.89 M | — | -38.51% | 999.19% | $4.88 / $1.8 | $-0.16 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 885 M | 821.5 M | 826.2 M | 776 M | 864.4 M | — |
| Operating Profit | 124.8 M | 135.1 M | 121.3 M | 89.6 M | 153 M | — |
| Net Profit | -15 M | -22.7 M | -2.5 M | -37.7 M | -108.5 M | — |
| EPS in Rs | -0.12 | -0.18 | -0.02 | -0.29 | -0.84 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 3.31 B | 3.11 B | 2.74 B | 2.54 B |
| Operating Profit | 470.8 M | 454.3 M | 408.5 M | 357.9 M |
| Net Profit | -77.9 M | -168.1 M | -11.9 M | -54.6 M |
| EPS in Rs | -0.6 | -1.3 | -0.09 | -0.42 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 8.12 B | 7.89 B | 6.88 B | 6.68 B |
| Total Liabilities | 4.59 B | 4.25 B | 3.51 B | 3.4 B |
| Equity | 1.71 B | 1.79 B | 1.99 B | 2 B |
| Current Assets | 1.15 B | 1.12 B | 895 M | 921 M |
| Current Liabilities | 615.5 M | 624.4 M | 523 M | 493.4 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 274.3 M | 300.1 M | 293.8 M | 158.8 M |
| Investing CF | -246.6 M | -488.5 M | -225.6 M | -307.9 M |
| Financing CF | -57.3 M | 262 M | -155.2 M | 42.1 M |
| Free CF | 195.6 M | 209.7 M | 205 M | 78.2 M |
| Capex | -78.7 M | -90.4 M | -88.8 M | -80.6 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 13.52% | 8.03% | — | — |
| Earnings Growth % | -1312.61% | 78.21% | — | — |
| Profit Margin % | -5.4% | -0.43% | -2.15% | — |
| Operating Margin % | 14.59% | 14.89% | 14.09% | — |
| Gross Margin % | 23.94% | 23.6% | 22.64% | — |
| EBITDA Margin % | 16.1% | 16.26% | 18.12% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.